Xander Wehrens Lab

Master
Heading

About the Lab

Content

Proper contraction and relaxation of the heart depends on the coordinated flux of calcium ions in and out of individual cardiac muscle cells. Research in our lab focuses on understanding how these calcium dynamics are regulated in normal and diseased hearts, and how abnormal intracellular calcium release may contribute to the development of cardiac arrhythmias, hypertrophy and heart failure.

We are particularly interested in the genetic and posttranslational regulation of key molecules involved in intracellular calcium handling, including the ryanodine receptor type 2 (RyR2), striated muscle preferentially expressed protein kinase (SPEG), and junctophilin-2 (JPH2).

Current major projects in the lab focus on the molecular basis of inherited arrhythmia syndromes like catecholaminergic polymorphic ventricular tachycardia, long QT syndrome and Wolff-Parkinson-White syndrome as well as other more complex, multifactorial cardiac diseases like atrial fibrillation and hypertrophic cardiomyopathy. These translational studies are aimed at developing new therapeutic targets for heart disease.

Heading

Funding Support

Content

R01 HL089598 Ryanodine receptor regulation in post-operative atrial fibrillation

R01 HL091947 Regulation of sarcoplasmic reticulum calcium release in heart failure

R01 HL117641 Determining the role of junctophilin-2 in cardiac disease

R01 HL147198 Mechanisms underlying atrial fibrillation associated with chronic kidney disease

Heading

Fellowship Support

Content

In addition, lab members are supported by fellowships from:

American Heart Association

NIH/NHLBI

Heart Rhythm Society

Heading

What’s at the ‘heart’ of a heartbeat?

Content

The laboratories of Dr. Xander Wehrens at Baylor College of Medicine and Dr. Stephan Lehnart at the University of Goettingen in Germany are making headway into understanding the molecular mechanisms that underlie atrial fibrillation.

Media Component
National Institutes of Health/Jill George
Graphic representation of DNA editing
Heading

Preventing sudden cardiac death with genome editing

Content

Dr. Xander Wehrens and his colleagues at Baylor College of Medicine study cardiac conditions, including inherited cardiac arrhythmia disorders. For this study, Dr. Wehrens teamed up with Dr. William Lagor to design a permanent treatment for catecholaminergic polymorphic ventricular tachycardia (CPVT).